bioAffinity Technologies Management
Management criteria checks 3/4
bioAffinity Technologies' CEO is Maria Zannes, appointed in Jan 2014, has a tenure of 10.33 years. total yearly compensation is $424.17K, comprised of 61.7% salary and 38.3% bonuses, including company stock and options. directly owns 1.75% of the company’s shares, worth $460.84K. The average tenure of the management team and the board of directors is 4.3 years and 6 years respectively.
Key information
Maria Zannes
Chief executive officer
US$424.2k
Total compensation
| CEO salary percentage | 61.7% |
| CEO tenure | 10.3yrs |
| CEO ownership | 1.7% |
| Management average tenure | 4.3yrs |
| Board average tenure | 6yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$424k | US$262k | -US$8m |
| Sep 30 2023 | n/a | n/a | -US$7m |
| Jun 30 2023 | n/a | n/a | -US$10m |
| Mar 31 2023 | n/a | n/a | -US$8m |
| Dec 31 2022 | US$385k | US$253k | -US$8m |
| Sep 30 2022 | n/a | n/a | -US$12m |
| Jun 30 2022 | n/a | n/a | -US$9m |
| Mar 31 2022 | n/a | n/a | -US$7m |
| Dec 31 2021 | US$264k | US$220k | -US$6m |
| Sep 30 2021 | n/a | n/a | -US$3m |
| Dec 31 2020 | US$286k | US$220k | -US$7m |
Compensation vs Market: Maria's total compensation ($USD424.17K) is below average for companies of similar size in the US market ($USD674.46K).
Compensation vs Earnings: Maria's compensation has increased whilst the company is unprofitable.
CEO
Maria Zannes (67 yo)
10.3yrs
Tenure
US$424,167
Compensation
Ms. Maria Zannes, J.D., serves as the President and Chief Executive Officer of bioAffinity Technologies, Inc. since 2014. Ms. Zannes is the Founder of bioAffinity Technologies, Inc. in 2014. She has been D...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman of the Board | 10.2yrs | US$248.75k | 7.3% $ 1.9m | |
| Founder | 10.3yrs | US$424.17k | 1.75% $ 460.8k | |
| VP & CFO | less than a year | US$338.92k | 0% $ 0 | |
| Chief Operating Officer | 7.3yrs | no data | 0.18% $ 46.6k | |
| Executive VP and Chief Medical & Science Officer | 8.3yrs | US$257.57k | 0.40% $ 105.9k | |
| Executive VP | no data | no data | 0.40% $ 105.6k | |
| Director of Communications | 1.3yrs | no data | no data | |
| National Director of Sales | less than a year | no data | no data | |
| Senior Vice President of Therapeutics | no data | no data | no data |
4.3yrs
Average Tenure
62yo
Average Age
Experienced Management: BIAF's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman of the Board | 10.2yrs | US$248.75k | 7.3% $ 1.9m | |
| Founder | 10.2yrs | US$424.17k | 1.75% $ 460.8k | |
| Independent Director | 6yrs | US$102.50k | 0.65% $ 172.6k | |
| Independent Director | 2.3yrs | US$105.00k | 0.035% $ 9.3k | |
| Independent Director | 10.2yrs | US$100.00k | 0.035% $ 9.3k | |
| Member of Science & Medical Advisory Board | no data | no data | no data | |
| Member of Science & Medical Advisory Board | 2.3yrs | no data | no data | |
| Independent Director | 6.6yrs | US$102.47k | 0.45% $ 118.1k | |
| Member of Science & Medical Advisory Board | no data | no data | no data | |
| Member of Science & Medical Advisory Board | no data | no data | no data | |
| Member of Scientific & Medical Advisory Board | 1.5yrs | no data | no data | |
| Director | less than a year | US$25.00k | 5.06% $ 1.3m |
6.0yrs
Average Tenure
72yo
Average Age
Experienced Board: BIAF's board of directors are considered experienced (6 years average tenure).